I t is a common clinical problem to be presented with a pediatric patient with IV access for which there is doubt about the usability of the catheter. Vascular access is often bandaged, obscuring clinical assessment, children may not be capable of verbally communicating pain at injection sites, and a "twiddler's syndrome" has been described in which the child manipulates the catheter, causing it to migrate out of the vessel. 1 Additionally, fluid leakage into surrounding tissue may initially go unnoticed owing to the distensibility of subcutaneous tissues in the very young. Even with infusion devices programmed to alarm in response to increasing infusion pressures, 2 hopefully allowing early identification of infiltration, the high compliance of subcutaneous tissues in children leads to failure of the alarm and reduces the effectiveness of this safety feature. 3 Moreover, manual IV boluses may generate higher pressures, resulting in rupture of fragile vessels. Traditionally, correct IV placement has been confirmed by a return flow of blood and gentle flushing of the cannula with saline and observation of the surrounding tissues. However, these methods are not consistently accurate because small-caliber vessels and potentially dehydrated patients do not allow return flow of blood, and highly compliant or edematous tissues may obscure extravasation of saline and give a false sense of security.
Infiltration, the unintentional leakage of IV fluids into the surrounding tissue, is the most common complication of vascular access. Extravasation, the leakage of IV medications into tissues can also occur. Both can cause injury, and the terms will be used interchangeably in this manuscript. The incidence of peripheral IV infiltration was reported to be 23%-78% for neonates 4 and 11%-28% for children, 5, 6 whereas percutaneous central venous catheters were reported to have an infiltration rate of 1% to 16%. 7 Extravasation of IV medications may result in tissue damage with the potential for skin necrosis, with tissue sloughing being reported in as many as 44% of infants with infiltrations. 8 Another important consequence of inappropriate placement of IV access is repeated cannulation. This procedure is stressful for both children and parents and has been rated as the most distressing part of hospital admissions and the cause of the most pain while in hospital. 9 Against this backdrop, there are multiple clinical scenarios in which there is a strong desire to confirm correct functioning of a doubtful "in situ" catheter.
Given the regular occurrence of the clinical dilemma already outlined, shortcomings of traditional methods, and the risk of tissue damage from extravasation, we decided to test a technique that may differentiate between an infiltrated IV catheter and a correctly sited catheter.
In this prospective controlled trial, the diagnostic utility of using IV-injected dilute 2.1% (0. 25 mEq/mL) and 1.05% (0.125 mEq/mL) sodium bicarbonate in mechanically ventilated children was tested. The technique is based on the observed phenomenon of increased end-tidal carbon dioxide (ETCO 2 ) concentration after the IV administration of sodium bicarbonate, 10 and mechanically ventilated children under general anesthesia were chosen because of the controlled setting and ability to accurately measure ETCO 2 and other physiological variables. In an effort to reduce the sequelae of extravasated sodium bicarbonate, which is hyperosmolar and highly alkaline, it was diluted with sterile water, and its physicochemical properties were tested. We have already investigated the value of the technique in mechanically ventilated adult patients and performed a safety study of subcutaneously injected sodium bicarbonate in rats; the results have recently been published. 11 Our aim in this study was to identify whether a lower concentration of sodium bicarbonate would still have diagnostic utility, investigate the effects of a bolus of diluted sodium bicarbonate on the unique physiology of children, and measure possible serum electrolyte changes.
METHODS
Institutional ethics committee approval was granted for this study, and prior written consent was obtained from the legal guardians of all children before enrollment. Eighteen ASA I-II patients ages 1 to 8 years undergoing elective surgery under general anesthesia with tracheal intubation and controlled mechanical ventilation were studied. General anesthesia was induced using a sevoflurane inhaled technique. Midazolam premedication was given at the discretion of the treating anesthesiologist. After induction of general anesthesia, a free-flowing 22-gauge IV cannula (BD Venflon, Helsingborg, Sweden) was placed in the upper limb of the patient. Correct IV placement was confirmed by free aspiration of blood. Rocuronium 0.5 mg/kg was then given, and the trachea was intubated with an appropriately sized cuffed endotracheal tube. The cuff was inflated until there was no detectable leak, with cuff pressure kept below 20 cmH 2 O. The ventilator was set at tidal volumes of 10 mL/kg of body weight, positive endexpiratory pressure of 5 cm/H 2 O, and respiratory rate (RR) of 15 breaths per minute. After tracheal intubation, and before surgery, a period of 5 minutes was allowed, at the end of which baseline ETCO 2 was established. The patient then received a 1 mL/kg bolus of 0.9% normal saline, 2.1% sodium bicarbonate, or 1.05% sodium bicarbonate. Sodium bicarbonate was diluted with sterile water and was analyzed for pH (Glass Electrode Radiometer, Copenhagen, Denmark) and osmolarity (Osmostation, OM 6050 A. Menarini Industries, Florence, Italy). Each patient received all 3 solutions given as a bolus and injected in a randomized order in 5-minute intervals. The injections were given through the cannula side-port close to the insertion site. Injection pressures were not measured, and no flush fluids were given. All injections and data collection occurred after induction of anesthesia and hemodynamic and ventilatory stabilization and before commencement of surgery. Injections were performed by an anesthesiologist not involved in the patient's anesthetic care so that the treating anesthesiologist remained blinded to the injectate. The data collected included patient demographics, ETCO 2 values during 11 consecutive breaths after the injection (S/5 anesthesia monitor; Datex Ohmeda now a division of GE Healthcare, Waukesha, WI), heart rate for 5 minutes after injection, and noninvasive arterial blood pressure measured 2.5 and 5 minutes after the injection. An increase of 10% in the ETCO 2 from baseline was considered a positive result. Venous blood samples were taken at baseline and 10 minutes after all 3 solutions had been injected. These venous blood samples were analyzed for pH and electrolyte levels. The blinded treating anesthesiologist was asked after each injection to determine whether sodium bicarbonate or normal saline had been given. A power analysis was conducted, with ␣ ϭ 0.05, 1 Ϫ ␤ ϭ 0.9, difference to be detected ϭ 2 mm Hg, with an SD of differences of 1 mm Hg. The minimum required sample size for a 2-sided paired t test ϭ 5 pairs, with 18 pairs allowing the power of the test to be 100%. Paired comparisons between ETCO 2 before and after injection as well as blood pH and electrolytes were made using the Student paired t test. A -square test of goodness of fit was performed to determine whether the blinded observers successfully detected the sodium bicarbonate or normal saline injections in the 18 patients. Data were analyzed using SPSS software (version 19; IBM Corp., Somers, NY).
RESULTS
The physical characteristics of the injected diluted sodium bicarbonate are outlined in Table 1 . Diluting sodium bicarbonate with sterile water decreased the osmolarity of the injectate from 2000 mOsm/L for the undiluted sodium bicarbonate to 447 mOsm/L for the diluted 2.1% sodium bicarbonate and 250 mOsm/L once diluted to 1.05%. The dilution did not have any effect on the pH of the injectate.
Eighteen patients ages 1 to 8 years old were enrolled in this study (mean age: 5 Ϯ 2 years). Mean patient weight was 22 Ϯ 8 kg (range 9 to 34 kg). Peak ETCO 2 increased by Ͼ10% in all patients after injection with dilute 2.1% sodium bicarbonate (from a mean value of 32.7 Ϯ 3.4 mm Hg to 39.0 Ϯ 3.5 mm Hg, P Ͻ 0.001). The peak ETCO 2 occurred in the second breath after the completion of the injection in 16 out of 18 patients and in the third breath in the remaining 2 of 18 patients. Injection with diluted 1.05% sodium bicarbonate resulted in a significant increase in ETCO 2 (from a mean value of 33.4 Ϯ 3.8 mm Hg to 36.3 Ϯ 3.4 mm Hg, P Ͻ 0.01), but reached a 10% increase in only 5 of the 18 patients (28%). Normal saline did not result in a significant increase in ETCO 2 levels (Fig. 1) . The blinded anesthesiologist could consistently detect the injection with 2.1% sodium bicarbonate, but the detection rate with 1.05% bicarbonate was 80%. All other physiological variables (RR, heart rate, blood pressure) remained unchanged. After injection, venous blood samples showed no increase in blood pH, serum sodium, or ionized calcium, and a small statistically significant, but clinically insignificant, increase in bicarbonate (Table 2) .
DISCUSSION
This study describes the novel use of a clinically observed phenomenon to confirm the correct placement and viability of an IV catheter placed in mechanically ventilated, endotracheally intubated pediatric patients. ETCO 2 increase after injection of 2.1% sodium bicarbonate appears to reliably confirm IV placement of an IV catheter. The use of 1.05% sodium bicarbonate is less reliable. Care should be taken if testing an IV cannula previously or concurrently being used for medications, because sodium bicarbonate may be incompatible with certain drugs, including epinephrine, norepinephrine, dobutamine, midazolam, calcium salts, and magnesium salts. The complications of extravasation from a nonfunctioning IV catheter can be serious. The American Society of Anesthesiologists Closed Claims Project database reflects this, with 2.1% of all claims (all ages) between 1975 and 2000 being related to peripheral catheters; of these, 28% were due to skin slough or necrosis and 17% were due to swelling, inflammation, or infection. 12 It was calculated that 55% of all complications were the result of extravasation of drugs or fluid. Given the seriousness of the problem of inadvertent extravasation with the potential for injury, increased costs, and risk of litigation, it would seem sensible to develop techniques, such as outlined above, that assist in preventing such negative outcomes. All IV medications and fluids can cause tissue damage, but certain substances are associated with a greater risk of tissue necrosis. 13 Moreover, though this study investigated confirmation of placement and patency of peripheral IV cannulas, the technique may be equally useful for central venous access catheters, and further studies in this setting are warranted. The consequences of misplaced or migrated central vascular access can be catastrophic with the potential for infusion of fluids into the pleural or abdominal cavity. Cardiovascular collapse could potentially occur should inotropic infusions be given through a catheter not positioned intravascularly. Overall, given the frequency of the problem, the potential complications and associated costs, and the distress caused to patients and families, a simple clinical test such as described in this study could beneficially impact health care spending attributable to hospital-acquired conditions and improve consumer satisfaction assessments. Any solution with osmolarity greater than plasma osmolarity causes damage by exerting an osmotic pressure leading to a compartment syndrome. Similarly highly alkaline solutions with pH above 9.0 can cause direct cellular injury, and it is recommended that infused solutions should have a pH between 5 and 9. 14 Potent vasoconstictors can also cause necrosis secondary to tissue ischemia. Drugs commonly used in the perioperative setting with the potential to cause tissue damage are listed in Table 3 , although other drugs not commonly associated with tissue damage still have the potential to cause injury, including propofol. 15 Vesicants are substances that have physical or chemical properties that make them capable of causing inflammation, pain, and blistering of tissues, potentially causing tissue death and necrosis, with injury to surrounding tissue if wrongly administered subcutaneously. Sodium bicarbonate is considered a vesicant secondary to its high pH and high osmorality. Although we did not specifically investigate the effect of subcutaneous injection of dilute sodium bicarbonate in pediatric patients, its minimally useful concentration is likely to enhance the safety of this technique by decreasing the osmolarity of the injectate. The safety of subcutaneous injection of dilute 4.2% sodium bicarbonate has been tested in a rat model and appears safe. 11 Notably, a useful minimum concentration (2.1% sodium bicarbonate) has been found for this technique in pediatric patients. Conspicuously, the peak increase in ETCO 2 was seen at the second to third breath, in contrast to the seventh breath in adults. 11 It is likely that this earlier increase is the result of the higher relative cardiac output and faster circulation time seen in children. It is likely that the technique is equally applicable to children whose lungs are ventilated via a laryngeal mask; however, spontaneously breathing patients may not exhibit the same CO 2 increase because they may partially compensate with an increased RR. Further studies that observe RR and exhaled CO 2 in pediatric patients with lung disease, spontaneously breathing, or awake pediatric patients may be warranted. Additional investigation may be useful to confirm the optimal volume, concentration, and total dose of sodium bicarbonate for this technique. Reassuringly, the 2.1% sodium bicarbonate bolus (0.25 mEq/kg), even if repeated several times a day, is well below the recommended 8 mEq/kg/day sodium bicarbonate dose limit for children younger than 2 years of age. Until further evidence suggests otherwise, we would consider contraindications to include premature infants, especially those with intraventricular hemorrhage, and children with increased intracranial pressure.
In summary, we present a useful technique, using 1 mL/kg of dilute 2.1% sodium bicarbonate and the resultant ETCO 2 increase, to confirm correct intravascular placement of peripheral IV cannulas in anesthetized, mechnically ventilated patients. No adverse events or complications were detected. This simple test may aid in reducing the complications of infiltration, and the patient and family distress caused by the common clinical scenario of the "doubtful" peripheral IV cannula. 
